Get my own profile
Public access
View all31 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Oleg A. IgoshinProfessor of Bioengineering, Rice UniversityVerified email at rice.edu
- Jatin NarulaPfizer Inc., Cambridge MAVerified email at pfizer.com
- Gábor BalázsiHenry Laufer Professor of Physical & Quantitative Biology, Stony Brook UniversityVerified email at stonybrook.edu
- Anson AbrahamPrincipal Scientist - Merck & Co., Inc.Verified email at merck.com
- Timothy HicklingImmunosafety Lead, RocheVerified email at roche.com
- Pratap Singhpfizer, Inc.Verified email at pfizer.com
- J. Christian J. RayComputational Biologist at Exosome Diagnostics / Bio-TechneVerified email at bio-techne.com
- Justin JuddPostdoctoral Fellow, Cardiovascular Research Institute, University of California, San FranciscoVerified email at ucsf.edu
- Junghae SuhHead of Gene Therapy Accelerator Unit, BiogenVerified email at biogen.com
- Jonathan (Joff) SilbergBiosciences, Bioengineering, and Chemical & Biomolecular Engineering, Rice UniversityVerified email at rice.edu
- Michelle HoRice UniversityVerified email at rice.edu
- Alejandro CrespoAmgenVerified email at amgen.com
- Paolo ViciniConfo TherapeuticsVerified email at u.washington.edu
- Liusong YinPostdoctoral Fellow, PfizerVerified email at umassmed.edu
- John HarroldSenior Scientist, Amgen IncVerified email at amgen.com
- Michael ManciniProfessor, Baylor College of MedicineVerified email at bcm.edu
- Gordon MillsOregon Health & Science UniversityVerified email at ohsu.edu
- John TolsmaRES GroupVerified email at resgroupinc.com